A new market study, titled “Indian Influenza Market By Product Type (Vaxigrip, Influvac)-Forecast 2020”, has been featured on WiseGuyReports.
The Indian Influenza market has reported a remarkable growth in recent years and is presenting ample opportunities to the industry’s players. With increasing pandemic as well as seasonal outbreak and rising awareness among people about these vaccines, the Indian influenza vaccine market is poised to scale newer acmes. Moreover, increasing disposable income, increasing incidences of influenza, introduction of new vaccines, entry of new players, and rising R&D investments are set to further boost the market’s growth. Owing to such factors, the Indian influenza market is anticipated to grow at a healthy CAGR during the forecast period (2015-2020).
In the report “Indian Influenza Market By Product Type (Vaxigrip, Influvac)-Forecast 2020”, analysts have endeavoured to address the current scenario of Indian influenza industry, factors favouring growth of the market, and the major roadblocks restraining the influenza vaccines market. Additionally, the report includes the study of opportunities, which are available in the Indian influenza market.
Furthermore, the report covers detailed description of the current scenario of the Indian influenza vaccine market, and its future forecast till 2020. Indian Influenza Vaccines market is analyzed in both volumes in doses, and value in US$ for the period from 2015 through to 2020. The report also provides detailed bifurcation of Indian influenza market on the basis of product type, such as Vaxigrip, Influvac, and others. The report also provides the potential market for influenza vaccines. Moreover, the report highlights the mergers and acquisitions that have taken place in the Indian influenza market. Pricing analysis along with the regulatory scenario governing the Indian influenza market has also been mentioned in the report. Furthermore, the report provides the details about the distribution channel for influenza vaccines in the Indian industry.
The latter half of the report provides competitive landscape including the market share of key players, such as Cipla Ltd., Bharat Biotech, Serum Institute of India, Abbott, Lupin Ltd, and others. A brief business overview and financial information about each of these players has been provided in the report, along with the company overviews and financial revenues of the key participants to develop their positions in the global market. The recent development and strength-weakness analysis of every player has also been presented to assist the investors in developing an understanding of the strategies of major players. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the Indian Influenza market.
Request Sample report at https://www.wiseguyreports.com/sample-request/1706501-indian-influenza-market-by-product-type-vaxigrip-influvac-forecast-2020
Table of Content
- Analyst View
- Research Methodology
- Influenza Vaccine – Introduction
- Market Dynamics
- Indian Influenza Market Outlook 2020
- Market Insights
- Competitive Landscape
- Key Players Analysis
8.1 Cipla Limited
8.2 Bharat Biotech
8.3 Panacea Biotec Limited
8.4 Zydus Cadilla
8.5 Lupin Ltd.
8.6 Abbott Laboratories
8.7 GlaxoSmithKline Plc (GSK)
8.8 Sanofi
8.9 CPL Biologicals Pvt. Ltd.
8.10 Serum Institute of India
8.11 Seqirus – A CSL Company
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
